Efficacy and Safety of Glucagon-Like Peptide  1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis

ConclusionRegimens of GLP-1RAs had differential glycemic control and cardiometabolic effectiveness. Policymaking and patient-centric clinical decisions should take into consideration the comparative effectiveness profiles.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research